Osaka, Japan

Sumie Sekiguchi

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sumie Sekiguchi. Retrieved from https://idiyas.com/inventor/sumie-sekiguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sumie Sekiguchi

Introduction

Sumie Sekiguchi is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on benzimidazole compounds. Her research focuses on creating stable forms of these compounds that exhibit superior water solubility.

Latest Patents

Sumie Sekiguchi holds a patent for a benzimidazole compound in crystal form and its salts. The patent, titled "Benzimidazole compound in crystal form and salt thereof," aims to provide a stable form of (R)-2-{3-[1-(acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide. This invention addresses issues related to water adsorption and enhances the compound's water solubility. She has 1 patent to her name.

Career Highlights

Sumie Sekiguchi is associated with Mitsubishi Tanabe Pharma Corporation, where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in developing new therapeutic options that can improve patient outcomes.

Collaborations

Throughout her career, Sekiguchi has collaborated with notable colleagues, including Takayuki Ishige and Masanori Minoguchi. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Sumie Sekiguchi's contributions to the field of pharmaceuticals through her innovative patent work exemplify her dedication to advancing medical science. Her research not only addresses critical challenges in drug formulation but also paves the way for future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…